Reducing Relapse with New MS Medication dailyRx Patients were assigned to take daclizumab or placebo (fake medication) every four weeks for 52 weeks. A total of 208 patients were assigned to 150 mg doses of daclizumab, 209 were assigned to 300 mg doses of daclizumab and 204 were assigned to ... |
